SCHEMBL24785366

SCHEMBL24785366

COC(=O)c1cc(Cl)cc2cnn(Cc3cnc(-c4ccc(OC)c(F)c4)nc3)c12

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.41
CACNA1H O95180 7/20 0.40
MCHR1 Q99705 1/20 0.38
ALDH1A1 P00352 1/20 0.37
MAPK1 P28482 1/20 0.37
GRM2 Q14416 1/20 0.37
KCNQ3 O43525 1/20 0.36
KCNQ2 O43526 1/20 0.36
ALKBH1 Q13686 1/20 0.36
PDGFRB P09619 1/20 0.36
PDGFRA P16234 1/20 0.36
PKM P14618 1/20 0.36
PKLR P30613 1/20 0.36
P2RX3 P56373 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
PTGIR P43119 1/20 0.35
PTGER4 P35408 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30018129 1.00 BRD4 (0.41) BRD4CACNA1HMCHR1ALDH1A1MAPK1
SCHEMBL24785079 0.94 CACNA1H (0.40) BRD4CACNA1HALKBH1
SCHEMBL30018338 0.94 CACNA1H (0.40) BRD4CACNA1HALKBH1
SCHEMBL30103017 0.92 ALKBH1 (0.40) BRD4CACNA1HMCHR1ALDH1A1MAPK1
SCHEMBL24785368 0.92 ALKBH1 (0.40) BRD4CACNA1HMCHR1ALDH1A1MAPK1
SCHEMBL30103083 0.90 BRD4 (0.41) BRD4CACNA1HMCHR1GRM2PKM
SCHEMBL24784564 0.86 NPBWR1 (0.41) BRD4MCHR1L3MBTL1
SCHEMBL30103029 0.86 NPBWR1 (0.41) BRD4MCHR1L3MBTL1
SCHEMBL24785076 0.86 ALKBH1 (0.41) CACNA1HALKBH1
SCHEMBL30103094 0.86 ALKBH1 (0.41) CACNA1HALKBH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022257960-A1 BICYCLIC COMPOUND FOR THE TREATMENT OF EP2 AND EP4 RECEPTOR-MEDIATED DISEASES 武汉人福创新药物研发中心有限公司 2022-12-15 WO disclosed